Leo Pharma

N/A

Ingenol Mebutate

N/A

Clinical Trials (1)

NCT03508856Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin

N/A

ingenol mebutate

N/A

Clinical Trials (1)

NCT02242747Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis

N/A

DLQI and PSO-TARGET QoL grid

N/A

Clinical Trials (1)

NCT04765332Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients

N/A

Seocalcitol

Liver Neoplasms

N/A

Clinical Trials (1)

NCT00051532Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

N/A

Thrombosis biomarkers

Cancer

N/A

Clinical Trials (1)

NCT04301362Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients

N/A

Villalta phone score > or = to 5

Post Thrombotic Syndrome

N/A

Ingenol Mebutate

N/A

Clinical Trials (1)

NCT02090465Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks

N/A

Ingenol mebutate

N/A

Clinical Trials (1)

NCT04202445TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction

N/A

Any topical drug treatment

N/A

Clinical Trials (1)

NCT03402828Body PSOriasis: Long-term Relapse CONTROL

N/A

Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curat

Venous Thromboembolism

N/A

Clinical Trials (1)

NCT01803022Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer

N/A

comprhensive spatial transcriptomic profile on lesional skin biopsies

Hand Eczema

N/A

Clinical Trials (1)

NCT06884163Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell Proteomics

N/A

A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of

N/A

Clinical Trials (1)

NCT00475605A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis

N/A

Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomi

Multiple Myeloma

N/A

Clinical Trials (1)

NCT01268774Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.

N/A

Ophthalmological Adverse Events of Tralokinumab in AD

N/A

Clinical Trials (1)

NCT05682976Ophthalmological Adverse Events of Tralokinumab in AD

N/A

Calcipotriol/betamethasone dipropionate gel

N/A

Clinical Trials (1)

NCT02636101Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study

N/A

Daivobet® Gel

N/A

Clinical Trials (1)

NCT01320774Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

N/A

Tinzaparin

Venous Thrombosis

N/A

Clinical Trials (1)

NCT00186745Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

N/A

Ingenol mebutate

Cancer-associated Thrombosis

N/A

Clinical Trials (1)

NCT02594436The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice

N/A

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient

N/A

Daivobet® Gel

N/A

Clinical Trials (1)

NCT01707368Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation

N/A

Thrombin Generation Assay

Cancer

N/A

Clinical Trials (1)

NCT06386107Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis

N/A

Ingenol mebutate 0.015 percent or 0.05 percent gel

N/A

Clinical Trials (1)

NCT02421471PMS to Evaluate the Safety and Efficacy of Picato® Gel

N/A

Tralokinumab

N/A

Clinical Trials (1)

NCT05938478Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

N/A

No intervention

Atopic Dermatitis (Moderate-to-severe) Involving the Genital Region

N/A

Clinical Trials (1)

NCT03358914The PsoTeenQOL - Preliminary Reliability and Validity

N/A

calcipotriol/betamethasone dipropionate gel in Applicator

Plaque Psoriasis

N/A

Clinical Trials (1)

NCT02856542Real-life Evaluation of the Daivobet® Gel Applicator

N/A

Xamiol® Gel

Scalp Psoriasis

N/A

Clinical Trials (1)

NCT01052467Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)

N/A

Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of

Skin Mycoses

N/A

tralokinumab

N/A

Clinical Trials (1)

NCT07444801Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact

N/A

PsoBest - The German Psoriasis Registry

N/A

An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Be

N/A

Clinical Trials (1)

NCT01982552An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life

N/A

Enstilar®

Plaque Psoriasis

N/A

Clinical Trials (1)

NCT02881346Efficacy and Tolerability of Enstilar® in Daily Practice

N/A

Ingenol mebutate

N/A

Clinical Trials (1)

NCT02362152The Real Life Topical Field Treatment of Actinic Keratosis Study

N/A

Enstilar® aerosol foam

N/A

Clinical Trials (1)

NCT02935582PSOREAL - Managing PSOriasis in the REAL World

N/A

Spanish Registry of Systemic Treatments in Psoriasis

N/A

BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients wit

N/A

Azelaic Acid Gel including: Finacea

Rosacea

N/A

Tinzaparin

Deep Vein Thrombosis

N/A

Clinical Trials (1)

NCT00967148Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer

N/A

Azelaic Acid

Rosacea

N/A

Tralokinumab administered as 1 × X mL with Device A

Healthy

Phase 1

Clinical Trials (1)

NCT04674826A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects

Phase 1

Clobetasol propionate 0.05% ointment

Skin Tissue Diseases

Phase 1

Clinical Trials (1)

NCT02392130A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin

Phase 1

Combination of clobetasol propionate plus calcipotriol ointment, clobetasol propionate ointment, calcipotriol ointment, and the ointment vehicle

Phase 1

Clinical Trials (1)

NCT01043224A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris

Phase 1

Azelaic Acid Foam

Papulopustular Rosacea

Phase 1

Microarray patch A